Pharmaceutical Packaging Market by Type (Bottle, Vial, Blister Pack, Ampoule, Pre-filled Syringe), Material (Plastic [PE, Polyvinyl chloride, PP, PET], Paper, Glass, Metal), Dosage Form (Oral, Parenteral, Topical), End User—Global Forecast to 2029

Pharmaceutical Packaging Market by Type (Bottle, Vial, Blister Pack, Ampoule, Pre-filled Syringe), Material (Plastic [PE, Polyvinyl chloride, PP, PET], Paper, Glass, Metal), Dosage Form (Oral, Parenteral, Topical), End User—Global Forecast to 2029

Pharmaceutical Packaging Market by Material (Polymer [PE, PP, PET], Glass, Paper, Metal) Type (Bottles, Blister, PFS, Caps, Vials, Ampoules, Sachet, Inhaler, Secondary, Tertiary) Dosage Form (Oral, Parenteral, Topical), End User–Global Forecast to 2031

The global pharmaceutical packaging market is projected to reach $176.54 billion by 2031 at a CAGR of 7.6% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the pharmaceutical packaging market is driven by growth in the pharmaceutical sector, the rising demand for drug delivery devices, growing healthcare expenditures, the increasing focus on biosimilars, the growing trend of contract manufacturing & packaging in the pharmaceutical sector, and growth in the aging population & the consequent rise in chronic disease prevalence. However, increasing instances of counterfeit packaging, increasing waste generation due to single-use packaging, and concerns over certain materials leaching into pharmaceutical preparations restrain the growth of this market.

Furthermore, the rising adoption of personalized medicines & self-medication, improving healthcare provisions in emerging economies, the growth in pharmaceutical R&D spending, and the increasing focus on vaccine development & vaccination coverage are expected to generate growth opportunities for the players operating in this market. However, changing regulatory regimes and changing market demands in the constantly evolving pharmaceutical landscape are major challenges impacting market growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2020–2024). The key players operating in the global pharmaceutical packaging market are Amcor plc (Switzerland), AptarGroup, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Gerresheimer AG (Germany), Schott Pharma AG & Co. KGaA (Germany), Berry Global Group, Inc. (U.S.), Drug Plastics Group (U.S.), Catalent, Inc. (U.S.), SGD Pharma (France), Corning Inc. (U.S.), WestRock Company (U.S.), and West Pharmaceutical Services, Inc. (U.S.).

Among all the materials studied in this report, the glass segment is projected to register the highest CAGR during the forecast period. The high growth of this segment is attributed to the benefits offered by glass packaging such as sustainable, inert, impermeable, resistant to temperature, recyclable with no loss in quality, and reusable. Additionally, glass is resistant to temperature, which is highly valuable to the pharmaceutical industry. Therefore, due to its safety, inertness, and impermeability, glass remains the preferred choice in pharmaceutical packaging, thereby driving growth.

Among all the packaging types studied in this report, in 2024, the primary packaging segment is expected to account for the largest share of the pharmaceutical packaging market. The large share of the segment is attributed to the increasing need for drug protection from external conditions and advancements in primary packaging. Additionally, the usage of pre-fillable syringes and inhalers is increasing due to the ease of use and the trend of self-medication. For instance, in May 2022, Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation (Japan), launched a pre-fillable polymer syringe for low-dose applications such as ophthalmic drugs.

Among all the dosage forms studied in this report, in 2024, the oral dosage form segment is expected to account for the largest share of the pharmaceutical packaging market. The large share of the segment is attributed to oral drug delivery being the most preferred route of administration due to patient compliance and ease of administration. Additionally, the advancements in oral drug packaging are further supporting the large share of the segment. For instance, advancements such as smart blister packaging, active packaging, utilization of sustainable materials, and patient-centric packaging designs are aimed at improving patient regimen compliance and enhancing the usability of formulations.

Among all the end users studied in this report, the contract companies segment is projected to register the highest CAGR during the forecast period. The high growth of the segment is attributed to the increasing outsourcing of pharmaceutical packaging to contract companies due to the complexities associated with the packaging, regulatory compliances, and mandatory serializations. By outsourcing serialization tasks, pharmaceutical companies can ensure compliance with requirements without investing significant time and resources in developing their procedures. For instance, in August 2021, Verifarma (Argentina) partnered with Himatrix (UAE) to provide pharmaceutical serialization solutions for companies in the Gulf region.

An in-depth analysis of the geographical scenario of the global pharmaceutical packaging market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of the pharmaceutical packaging market. In the region in 2024, the U.S. is expected to account for the largest share of the pharmaceutical packaging market in North America. The large share of the country is attributed to government support for the growth of the pharmaceutical sector, the growing shift towards the self-administration of drugs, and the strong healthcare and pharmaceutical sector in the country. Additionally, major players operating in the packaging automation sectors are increasingly entering the U.S. market. For instance, in January 2022, Sewtec Automation Ltd. (U.K.) partnered with TurboFil Packaging Machines, LLC (U.S.) to emphasize Sewtec's pharmaceutical, medical device, personal care, and cosmetics end-of-line packaging solutions in the U.S. market. Thus, increasing automation in the packaging sector in the region contributes to the segment’s large share.

Scope of the Report:

Pharmaceutical Packaging Market Assessment—by Material

Polymer
Polyvinyl Chloride (PVC)
Polyethylene Terephthalate (PET)
Polypropylene (PP)
Polyethylene (PE)
Other Polymers
Glass
Paper & Paperboard
Metal
Other Packaging Materials

Note: Other polymer materials include Cyclic Olefin Polymer (COP) and Polystyrene

Note: Other packaging materials include rubber, silica gel, and wood

Pharmaceutical Packaging Market Assessment—by Packaging Type

Primary Packaging
Blister Packaging
Bottles
Vials & Ampoules
Caps & Closures
Pre-fillable Inhalers
Pre-fillable Syringes & Cartridges
Pouches & Sachets
Other Primary Packaging
Secondary Packaging
Tertiary Packaging

Note: Other primary packaging includes jars & canisters, medication tubes, strip packs, specialty bags, and accessories

Pharmaceutical Packaging Market Assessment—by Dosage Form

Oral Dosage Form
Oral Solid Dosage
Oral Liquid Dosage
Parenteral Dosage Form
Other Dosage Forms

Note: Other dosage forms include topical, nasal, dermal, and ocular dosage forms

Pharmaceutical Packaging Market Assessment—by End User

Pharmaceutical Companies
Contract Companies
Pharmacies

Pharmaceutical Packaging Market Assessment—by Geography

North America
U.S.
Canada
Europe
Switzerland
Italy
Germany
France
U.K
Ireland
Belgium
Spain
Denmark
Rest of Europe (RoE)
Asia-Pacific (APAC)
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific (RoAPAC)
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa

Pharmaceutical Packaging Market - Report Summary

Report Metrics	Details
Years Considered	2022 - 2031
Base Year	2023
Forecast Period	2024-2031
Page Count	348
Units Referenced	Value (USD Million)
Segments/Key Topics	Market by Material, Packaging Type, Dosage Form, End User, and Geography
Regions Covered	North America (U.S., Canada), Europe (Switzerland, Italy, Germany, France, U.K., Ireland, Belgium, Spain, Denmark, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America), and Middle East & Africa
Key Companies Mentioned	Amcor plc (Switzerland), AptarGroup, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Gerresheimer AG (Germany), Schott Pharma AG & Co. KGaA (Germany), Berry Global Group, Inc. (U.S.), Drug Plastics Group (U.S.), Catalent, Inc. (U.S.), SGD Pharma (France), Corning Inc. (U.S.), WestRock Company (U.S.), and West Pharmaceutical Services, Inc. (U.S.).

Key questions answered in the report:

What is the focus of the pharmaceutical packaging market study?

The global pharmaceutical packaging market covers the study of various materials used for pharmaceutical packaging manufacturing, along with the packaging type, dosage form, and end user. This report also involves the analysis of various segments of pharmaceutical packaging at the regional and country levels.

What is the revenue generated from the sales of pharmaceutical packaging across the globe?

The global pharmaceutical packaging market is projected to reach $176.54 billion by 2031 at a CAGR of 7.6% from 2024 to 2031.

Which material is estimated to hold the major share of the market in 2024?

Among all the materials studied in this report, in 2024, the polymer segment is expected to account for the largest share of the pharmaceutical packaging market. The segment’s large share is attributed to the wide availability of polymers, the cost-effectiveness of polymers compared to other packaging materials, such as glass and metal, and the effectiveness of polymers in protecting pharmaceutical preparations against external damage and contamination.

Which packaging type is estimated to hold the major share of the market in 2024?

Among all the packaging types studied in this report, in 2024, the primary packaging segment is expected to account for the largest share of the pharmaceutical packaging market. This large share is attributed to the high volume of pharmaceutical production and advancements in primary packaging and drug delivery devices. Additionally, with the rising number of drug approvals, the demand for primary packaging is increasing.

What are the key factors supporting the growth of this market? Also, what are the major opportunities for existing market players and new entrants in the global pharmaceutical packaging market?

The growth of the pharmaceutical packaging market is driven by growth in the pharmaceutical sector, the rising demand for drug delivery devices, growing healthcare expenditures, the increasing focus on biosimilars, the growing trend of contract manufacturing & packaging in the pharmaceutical sector, and growth in the aging population & the consequent rise in chronic disease prevalence.

Furthermore, the rising adoption of personalized medicines & self-medication, improving healthcare provisions in emerging economies, the growth in pharmaceutical R&D spending, and the increasing focus on vaccine development & vaccination coverage are expected to generate growth opportunities for the players operating in this market.

Who are the major players operating in the global pharmaceutical packaging market?

The key players operating in the global pharmaceutical packaging market are Amcor plc (Switzerland), AptarGroup, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Gerresheimer AG (Germany), Schott Pharma AG & Co. KGaA (Germany), Berry Global Group, Inc. (U.S.), Drug Plastics Group (U.S.), Catalent, Inc. (U.S.), SGD Pharma (France), Corning Inc. (U.S.), WestRock Company (U.S.), and West Pharmaceutical Services, Inc. (U.S.).

Which regions/countries are likely to offer significant growth opportunities for the vendors in this market during the analysis period?

The countries in Asia-Pacific are projected to offer significant growth opportunities for the vendors in this market. Countries such as India and South Korea are expected to grow with considerable CAGR in the pharmaceutical packaging market. The growth of the pharmaceutical packaging market in India is driven by the growth in domestic consumption of pharmaceuticals and the increasing manufacturing of several pharmaceutical products in the country. Furthermore, government initiatives supporting the growth of pharmaceutical manufacturing in the country are expected to drive the market's growth. Additionally, companies operating in South Korea are actively focusing on increasing their presence in the country due to the potential market opportunities and supportive government initiatives. For instance, in August 2021, ExoCoBio, Inc. (South Korea) started building its drug manufacturing and research & development facilities in South Korea.